Cep Halos Por Ines

download Cep Halos Por Ines

of 6

Transcript of Cep Halos Por Ines

  • 8/18/2019 Cep Halos Por Ines

    1/6

     

    These are the second major group of Beta-lactam, broad spectrum penicillinase

    resistance antibiotics derived from the microoraganism Acrimonium chrysogenum.It was

     previously known as Cephalosporium’’.It was found in a sewage outfall off the !ardinian

    coast in "#$% by Italian scientist &iuseppe Brot'u. (ephalothin )cefalotin* ,the first agent was

    launched by +li illy in "#$.

     MODE OF ACTION 

      (ephalosporins are bactericidal agents and have the same mode of action as other beta-

    lactam antibiotics.The cell wall protects the all bacterial cells. (ephalosporins interrupt the

    synthesis of the peptidoglycan layer of bacterial cell walls, which causes the walls to break 

    down and finally the bacterial death. eptidoglycan is a heteropolymeric component and it

     provides rigid mechanical stability of the cell wall.The last transpeptidation step in the

    synthesis of the peptidoglycan is facilitated by transpeptidases known as penicillin binding

     protein.These proteins bind to the /-Ala-/-Ala at the end of muropeptides )peptidoglycan

     precursors* to crosslink the peptidoglycan. (ephalosporins mainly mimic the structure of the

    /-Ala-/-Ala link and disrupting the cross-linking process. If the peptidoglycan fails to

    cross-link the cell wall it loose the strength of the wall and cell lysis occurs.

     

    CLASSIFICATION OF CEPHALOSPORIN

      They are grouped into generations based mainly on their spectrum of antimicrobial

    activity. 0ewer generation of cephalosporins has significantly greater gram-negative

    antimicrobial spectrum than the previous one, and decreased activity against gram-positive

    organisms. The newer generations have much longer half-lives resulting in the decrease of 

    dosing fre1uency. 2ourth generation cephalosporins have true broad spectrum activity.

    FIRST GENERATION

      Cephalexin, po

    Cefazolin

    Cephalothin

    Cephradine, po

  • 8/18/2019 Cep Halos Por Ines

    2/6

    It mainl a!t" on #ram po"iti$e %a!teria&

    'SES

      3pper respiratory tract infections due to !taphylococcus and !treptococcus, ower 

    respiratory tract infections due to susceptible bacteria e.g. !trep. neumonia in penicillin-

    allergic patient )previous rash,. 3ncomplicated urinary tract infections )(ephale4in*, surgical

     prophyla4is for orthopedic and cardiovascular operations )cefa'olin preferred because of 

    longer half-life*, !taphylococcal infections of skin and skin structure

    2+AT35+!

    6They have relatively short half- lives. oor ability to penetrate into cerebrospinal fluid

    6They have narrow spectrum of antibacterial activity.

    6They are resistant to 7- lactamase produced by &r 8ve bacteria only.

    Spe!tr(m of a!ti$it)

    &ood coverage on gram positive cocci 9 Streptococci, Staphylococci, Enterococci.

     0:T effective against methicillin-resistant Staph. aureus, penicillin-resistant Strep.

     pneumoniae.

    ;odest coverage on gram negative cocci9 Escherichia coli, Proteus mirabilis, and Klebsiella

     pneumoniae, though susceptibilities may vary. oor activity against  Moraxella

    catarrhalis and Hemophilus influenzae.

    Active against most of the penicillin-susceptible anaerobes that are found in the oral cavity,

    e4cept Bacteroides frailis group.

      ;ost commonly used "st generation cephalosporin is (efa'olin.It had increased risk of 

    cross-reactivity in penicillin-allergic patients in comparison with other cephalosporins .

     !+(:0/ &+0+5ATI:0

    *Tr(e* "e!ond #eneration in!l(de")

    cefpro'il )(ef'il*

  • 8/18/2019 Cep Halos Por Ines

    3/6

    • cefuro4ime )(eftin,

  • 8/18/2019 Cep Halos Por Ines

    4/6

  • 8/18/2019 Cep Halos Por Ines

    5/6

    &ram-positive cocci9 articularly agents available in an oral formulation have limited activity

    against gram-positive cocci. (efota4ime and ceftria4one have increased potency against

     penicillin-resistant pneumococci compared with first- and second-generation agents. But

    (efi4ime and (eftibuten lack Staphylococcus activity.

    '"e")

     

    3pper respiratory tract infections

     

    :titis media

     

    &ram-negative bacillary meningitis

     

    !erious infections of +nterobacteriaceae

     

    yelonephrits

     

    !kin and soft tissue infections

     

    yme disease and gonorrhoea-(eftria4one

    enetration into the cerebrospinal fluid-(efota4ime, cefta'idime, ceftria4one,

    cefti'o4ime, and mo4alactam

      (ephalosporins are not the drugs of choice for +nterobacter infections, because they

    have a tendency to become resistant during cephalosporin therapy.

    AntiP"e(domonal Cephalo"porin"

    (efta'idime )2orta', Ta'icef, Ta'idime* and (efopera'one )(efobid* are the two third

    generation cephalosporins with antipseudomonal activity.

    Spe!tr(m of a!ti$it) ;ain indication is Pseudomonas aeruinosa 

    2:35T> &+0+5ATI:0

      It has the broadest spectrum of activity. (urrently available fourth generation

    cephalosporin is cefepime. They have similar activity against gram-positive organisms as first

    generation cephalosporins and have a greater resistance to beta-lactamases than the third

    generation cephalosporins. It includes cefepimcefluprenam, cefo'opran, cefpirome,

    cef1uinome.

  • 8/18/2019 Cep Halos Por Ines

    6/6

    Spe!tr(m of a!ti$it)

    Broad coverage of gram positive and gram negative organisms. &ram-positive cocci

    like Streptococcus pneumoniae, &roups A and B streptococci, methicillin-

    susceptible Staphylococcus aureus )less potent than the "st and nd generation agents* and

    &ram-negative bacteria like +nterobacteriaceae and seudomonas aeruginosa.They had

    increased activity compared to Crd generation. But minimal anaerobic coverage.

    '"e") 

    >ighly active against nosocomial pathogens sand are primary used for nosocomial infections-

    (efepime and cefpirome.They can cross blood-brain barrier and can be used in the treatment

    of meningitis.

    2I2T> &+0+5ATI:0

      They have similar gram negative coverage to third- and fourth-generation agents and

    enhanced coverage of gram positive organisms9 ;5!A, !. pneumonia, and +. faecalis .But

    anaerobic activity is limited.It includes drugs like ceftaroline fosamil ,ceftobiprole .

    !I/+ +22+(T!

    &I system-/iarrhoea, nausea, mild stomach cramps or upset

    Allergic reactions9 anaphyla4is )rare*, rash )maculopapular, urticarial*, serum sickness-like

    reaction, eosinophilia, interstitial nephritis.

      :ther side effects are black, tarry stools painful or difficult urination antibiotic-induced

    colitis )severe watery diarrhea, severe stomach cramps, fever, and weakness*.